Vaneck Vectors Global Health Leaders ETF (ASX:HLTH)
Australia
· Delayed Price · Currency is AUD 11.70
-0.11 (-0.93%)
At close: Feb 27, 2026
0.00% (1Y)
| Assets | 51.76M |
| Expense Ratio | 0.45% |
| PE Ratio | 17.86 |
| Dividend (ttm) | 0.02 |
| Dividend Yield | 0.17% |
| Ex-Dividend Date | Jul 1, 2025 |
| Payout Frequency | Annual |
| Payout Ratio | 3.01% |
| 1-Year Return | n/a |
| Volume | 3,374 |
| Open | 11.74 |
| Previous Close | 11.81 |
| Day's Range | 11.70 - 11.74 |
| 52-Week Low | 10.36 |
| 52-Week High | 13.00 |
| Beta | 0.38 |
| Holdings | 10 |
| Inception Date | Sep 8, 2020 |
About HLTH
HLTH.AX was created on 2020-09-08 by VanEck. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investment returns before fees and other costs which track the performance of the Reference Index in Australian dollars.
Asset Class Equity
Category Health Care
Stock Exchange Australian Securities Exchange
Ticker Symbol HLTH
Provider VanEck
Index Tracked MarketGrader Developed Markets ex-Australia Health Care Index - AUD
Performance
HLTH had a total return of 0.18% in the past year. Since the fund's inception, the average annual return has been 3.30%, including dividends.
Top 10 Holdings
25.88% of assets| Name | Symbol | Weight |
|---|---|---|
| Globus Medical, Inc. | GMED | 3.00% |
| Swedish Orphan Biovitrum AB (publ) | SOBI | 2.78% |
| Chugai Pharmaceutical Co., Ltd. | 4519 | 2.65% |
| Merck & Co., Inc. | MRK | 2.63% |
| Regeneron Pharmaceuticals, Inc. | REGN | 2.51% |
| Amgen Inc. | AMGN | 2.50% |
| Johnson & Johnson | JNJ | 2.49% |
| Eli Lilly and Company | LLY | 2.46% |
| Illumina, Inc. | ILMN | 2.44% |
| Bristol-Myers Squibb Company | BMY | 2.41% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jul 1, 2025 | 0.020 AUD | Jul 25, 2025 |
| Jul 1, 2024 | 0.090 AUD | Jul 23, 2024 |
| Jul 3, 2023 | 0.110 AUD | Jul 25, 2023 |
| Jul 1, 2022 | 0.060 AUD | Jul 25, 2022 |
| Jul 1, 2021 | 0.040 AUD | Jul 23, 2021 |